Analysis of Clinical Arterial and Metabolic Parameters in Chronic Phase CML Patients On Nilotinib in a Single Center Cohort
Hélène Labussière‐Wallet, Franck E. Nicolini(Inserm), Madeleine Etienne(Hôpital Lyon Sud), Stéphane Morisset(Lyon 1 Université), Yann Guillermin(Hôpital de la Croix-Rousse), Fiorenza Barraco(Hôpital Lyon Sud), Anne-Claire Barale(Hôpital Lyon Sud), Isabelle Tigaud(Inserm), Oriane Le Borgne(Hôpital Lyon Sud), Mohamad Sobh(Ottawa Hospital), Sandrine Hayette(Hôpital Claude Huriez), Mauricette Michallet(Université Claude Bernard Lyon 1), Caroline Serrier(Hôpital Lyon Sud)
Cited by 10
Related Papers
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
|The Lancet Haematology|2016|431